EMERTH BIO is a biotechnology startup located in Anhe Pharmaceutical Valley, Qiantang District, Hangzhou, Zhejiang, China. Leveraging the resources of Hangzhou's biopharmaceutical industry cluster, the company focuses on two core business areas: ADC/XDC bioconjugation technology development and customized synthesis of pharmaceutical small-molecule intermediates.
Our product and service portfolio includes PEG derivatives, ADC/XDC linkers, linker-payloads,bioconjugation services,PROTAC-related compounds,specialized chemical building blocks,fluorescent probes,and other innovative molecular solutions.
We provide pharmaceutical companies, CROs, and academic research institutions with integrated R&D support, covering process development, sample synthesis, and analytical testing and quality control. Through flexible, customer-oriented chemistry solutions, EMERTH BIO aims to support pharmaceutical research, drug discovery, and the development of innovative therapeutics.